Dominick Colangelo's Net Worth
$33.4 Million
Who is Dominick Colangelo?
Dominick Colangelo has an estimated net worth of $33.4 Million. This is based on reported shares across multiple companies, which include Vericel Corp, Trevi Therapeutics, Inc., and OSCIENT PHARMACEUTICALS CORP.
SEC CIK
Dominick Colangelo's CIK is 0001313403
Past Insider Trading and Trends
2024 was Dominick Colangelo's most active year for acquiring shares with 49 total transactions. Dominick Colangelo's most active month to acquire stocks was the month of January. 2021 was Dominick Colangelo's most active year for disposing of shares, totalling 20 transactions. Dominick Colangelo's most active month to dispose stocks was the month of January. 2015 saw Dominick Colangelo paying a total of $1,328,800.00 for 440,000 shares, this is the most they've acquired in one year. In 2021 Dominick Colangelo cashed out on 184,201 shares for a total of $7,287,298.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vericel Corp (VCEL) Snapshot price: $45.22
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$21.94 | -$1,324,400.00 | 220.94K |
Oct 16 - Oct 17
| |||
Form 4
|
—
|
0
|
$23.33 | -$1,421,525.00 | 220.94K |
Sep 11 - Sep 12
| |||
Form 4
|
—
|
0
|
$24.37 | -$1,493,975.00 | 220.94K |
Aug 14 - Aug 15
| |||
Form 4
|
—
|
0
|
$27.25 | -$1,695,925.00 | 220.94K |
Jul 17 - Jul 18
| |||
Form 4
|
—
|
0
|
$23.32 | -$1,420,650.00 | 220.75K |
Jun 12 - Jun 13
| |||
Form 4
|
—
|
0
|
$25.89 | -$1,600,900.00 | 220.75K |
May 15 - May 16
| |||
Form 4
| +13.03% | 25.45K |
$11.79 | $299,976.92 | 220.75K |
Apr 30
| |||
Form 4
|
—
|
0
|
$24.28 | -$1,487,850.00 | 195.31K |
Apr 17 - Apr 18
| |||
Form 4
|
—
|
0
|
$23.69 | -$1,446,375.00 | 194.87K |
Mar 13 - Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +11.99% | 20.86K |
$49.50 | -$892,237.50 | 194.87K |
Feb 20
| |||
Form 4
|
—
|
0
|
$25.47 | -$1,571,500.00 | 174.01K |
Feb 14 - Feb 15
| |||
Form 4
| +2.37% | 4.02K |
$47.42 | -$164,879.34 | 174.01K |
Feb 12
| |||
Form 4
|
—
|
0
|
$20.65 | -$1,179,350.26 | 169.99K |
Jan 17 - Jan 18
| |||
Form 4
| -3.82% | -6.76K |
$19.58 | -$768,120.00 | 169.99K |
Dec 13 - Dec 14
| |||
Form 4
|
—
|
0
|
$18.86 | -$745,811.42 | 176.74K |
Dec 6 - Dec 7
| |||
Form 4
| +1.60% | 11.07K |
$29.82 | -$285,258.12 | 703.21K |
Feb 17 - Feb 19
| |||
Form 4
| +2.48% | 3.98K |
$29.30 | -$102,989.50 | 164.74K |
Feb 11
| |||
Form 4
| +2.35% | 3.69K |
$30.60 | -$99,541.80 | 160.75K |
Feb 6
| |||
Form 4
|
—
|
0
|
$26.47 | -$53,197.42 | 157.07K |
Scheduled
|
Jan 10
| ||
Form 4
| +3.34% | 5.06K |
$34.90 | -$135,237.50 | 156.43K |
Feb 18 - Feb 19
| |||
Form 4
| +2.89% | 4.25K |
$35.26 | -$114,630.26 | 151.37K |
Feb 11
| |||
Form 4
| +2.71% | 3.89K |
$33.91 | -$103,391.59 | 147.12K |
Feb 6
| |||
Form 4
| -18.49% | -32.44K |
$41.91 | -$2,125,077.50 | 142.97K |
Scheduled
|
Apr 19
| ||
Form 4
| -15.66% | -32.50K |
$38.41 | -$1,846,753.87 | 175.05K |
Scheduled
|
Mar 29 - Mar 30
| ||
Form 4
| -5.31% | -11.64K |
$25.96 | -$1,816,531.28 | 207.55K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| +1.97% | 4.23K |
$49.23 | -$160,834.41 | 219.19K |
Feb 11
| |||
Form 4
| +1.83% | 3.86K |
$47.18 | -$145,220.04 | 214.96K |
Feb 6
| |||
Form 4
| +6.65% | 13.13K |
$2.75 | $36,093.75 | 210.49K |
May 8
| |||
Form 4
| +13.56% | 23.44K |
$2.40 | $56,204.10 | 196.23K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
| +2.22% | 3.76K |
$17.28 | -$54,933.12 | 172.79K |
Feb 6
| |||
Form 4
| +49.87% | 56.25K |
$2.65 | $149,062.50 | 169.03K |
Oct 1 - Oct 2
| |||
Form 4
|
—
|
0
|
$8.82 | -$704,806.31 | 112.78K |
Scheduled
|
Oct 1
| ||
Form 4
| +48.15% | 36.19K |
$2.76 | $99,999.40 | 111.36K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
$9.07 | -$632,000.00 | 75.16K |
Scheduled
|
Nov 6
| ||
Form 4
|
—
|
0
|
$8.49 | -$980,250.00 | 75.16K |
Scheduled
|
Oct 4
| ||
Form 4
| +0.65% | 474 |
$8.15 | -$337,695.64 | 73.56K |
Scheduled
|
May 16 - May 17
| ||
Form 4
| +91.42% | 34.1K |
$3.13 | $106,622.71 | 71.41K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
∞
| 20K |
$2.55 | $51,000.00 | 20K |
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trevi Therapeutics, Inc. (TRVI) Snapshot price: $2.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OSCIENT PHARMACEUTICALS CORP No price found
EVP Corporate Dev & Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +46.14% | 14.67K |
—
|
—
| 46.47K |
Feb 25
| |||
Form 4
| +6.71% | 2K |
$1.24 | $2,479.00 | 31.8K |
Feb 8
| |||
Form 4
| +191.13% | 19.56K |
—
|
—
| 29.8K |
Mar 7
| |||
Form 4
|
∞
| 80K |
—
|
—
| 80K |
Feb 27
| |||
Form 4
|
∞
| 1.87K |
$2.25 | $4,216.50 | 1.87K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||